Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

November 7, 2025

WATERTOWN, Mass., November 7, 2025 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)

March 27, 2026

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

WATERTOWN, Mass., March 27, 2026 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)... Read More

February 24, 2026

Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives

WATERTOWN, Mass., February 24, 2026 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)... Read More

December 18, 2025

Werewolf Therapeutics Announces Pipeline and Business Updates

WATERTOWN, Mass., December 18, 2025 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)... Read More

Share this article: